Centene Co. (NYSE:CNC) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC lifted its stake in Centene Co. (NYSE:CNC) by 35.6% in the fourth quarter, HoldingsChannel reports. The firm owned 3,914 shares of the company’s stock after acquiring an additional 1,028 shares during the quarter. GAMMA Investing LLC’s holdings in Centene were worth $237,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Park Place Capital Corp grew its position in shares of Centene by 1,190.0% during the third quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares in the last quarter. Private Trust Co. NA increased its position in shares of Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after purchasing an additional 332 shares during the last quarter. True Wealth Design LLC acquired a new stake in shares of Centene in the 3rd quarter valued at $66,000. Venturi Wealth Management LLC grew its stake in shares of Centene by 77.3% during the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after purchasing an additional 507 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in Centene by 104.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,231 shares of the company’s stock valued at $82,000 after buying an additional 630 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Thomas Greco bought 17,000 shares of the firm’s stock in a transaction on Wednesday, December 18th. The shares were bought at an average cost of $59.75 per share, for a total transaction of $1,015,750.00. Following the transaction, the director now owns 19,309 shares of the company’s stock, valued at approximately $1,153,712.75. This trade represents a 736.25 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Sarah London purchased 4,117 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $60.80 per share, with a total value of $250,313.60. Following the acquisition, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders bought 45,010 shares of company stock worth $2,660,276. 0.33% of the stock is owned by insiders.

Centene Trading Down 0.3 %

NYSE:CNC opened at $62.52 on Wednesday. The stock’s 50 day simple moving average is $60.08 and its 200-day simple moving average is $67.56. Centene Co. has a 12-month low of $55.03 and a 12-month high of $81.42. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. The firm has a market cap of $31.56 billion, a P/E ratio of 10.85, a PEG ratio of 0.78 and a beta of 0.45.

Analyst Ratings Changes

CNC has been the subject of several analyst reports. Truist Financial lowered their price objective on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research report on Friday, December 13th. Stephens dropped their price target on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research note on Friday, December 13th. Cantor Fitzgerald restated an “overweight” rating and issued a $90.00 target price on shares of Centene in a report on Wednesday, December 11th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Finally, Sanford C. Bernstein dropped their price objective on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a report on Wednesday, October 30th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Centene has a consensus rating of “Moderate Buy” and an average price target of $80.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.